- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04158609
Relationship Between Delivery Route and Fetal Complications With Doppler Indices and CPR Parameters (Doppler)
Assessment of the Relationship Between Delivery Route, Umbilical Cord pH and Fetal Complications With Doppler Parameters Measured Prior to Induction of Labor at Term Pregnancies.
Study Overview
Status
Intervention / Treatment
Detailed Description
Term pregnancies within their 37-41 gestational week, who were planned to undergo induction of labor, were included in the study. Prior to initiation of the induction of labor, all included pregnant women underwent an assessment of Doppler flow indices, which included fetal umblical artery PI (pulsatility index) and fetal middle cerebral artery (MCA:Middle cerebral arter) PI. Cerebroplacental Ratio (CPR) was calculated by dividing MCA PI value to umbilical artery PI (MCA PI/UA PI=CPR).Included pregnant women were categorized as Group 1 and Group 2, which comprised of those with CPR value below 1.0 and above 1.0, respectively. All women who were considered appropriate for induction of labor were performed an pelvic examination and their Bishop scores were calculated. Those with a Bishop score equal to or below 5 were included in the study. Vaginal misoprostol (prostoglandin E1, 25 mcg) and dinoproston (prostoglandin E2, 10 mg) were used for induction of labor. Repeat doses were implemented in case of insufficient cervical ripening. Oxytocin was not used at the initial stages of labour, while it was used at the latter stages when necessary.
Route of delivery and fetal complications, described as umbilical cord pH<7.20, APGAR score at 5 minutes <7, meconium aspiration syndrome, newborn intensive care unit admission, neonatal sepsis and neonatal death.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
İstanbul, Turkey, 34722
- Istanbul Medeniyet University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Term pregnancies between 37 and 41 gestational weeks Pregnancies destined to induction of labor
Exclusion Criteria:
- history of uterine scar, nonverteks presentation, multiple pregnancies, use of vacuum of forceps at delivery, shoulder dystocia, confirmed fetal structural or chromosomal anomalies
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Group 1
Pregnant women with CPR value below 1, based on Doppler indices assessment
|
Doppler flow indices, UA-PI, MCA-PI and CPR values, assessment performed prior to induction of labor
|
Group 2
Pregnant women with CPR value equal to or above 1, based on Doppler indices assessment
|
Doppler flow indices, UA-PI, MCA-PI and CPR values, assessment performed prior to induction of labor
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Umblical arter pH
Time Frame: Within 1-3 minutes following delivery
|
Umbilical cord blood sampling just after the delivery of the newborn and pH measurement
|
Within 1-3 minutes following delivery
|
APGAR score at 5 minutes
Time Frame: Postpartum 5 minutes
|
APGAR score determined by the pediatrician at postpartum 5 minutes
|
Postpartum 5 minutes
|
Meconium aspiration syndrome
Time Frame: Within postpartum two weeks
|
Meconium aspiration syndrome diagnosed by the pediatrician, either clinically or by thorax X-ray film.
|
Within postpartum two weeks
|
Newborn intensive care unit administration
Time Frame: Within postpartum 1 month period
|
Newborn intensive care unit administration, due to a variety of conditions, which were established by pediatrician
|
Within postpartum 1 month period
|
Neonatal sepsis
Time Frame: Within postpartum 1 month period
|
Neonatal sepsis diagnosed by the pediatrician
|
Within postpartum 1 month period
|
Neonatal death
Time Frame: Within postpartum 1 month period
|
Neonatal death
|
Within postpartum 1 month period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Route of delivery
Time Frame: At the time of delivery
|
Route of delivery, either vaginally or by cesarean section
|
At the time of delivery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2018/0473
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fetal Complications
-
Raydiant Oximetry, Inc.Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingOxygen Deficiency | Fetal Complications | Fetal Hypoxia | Fetal Conditions | Fetal Distress | Labor (Obstetrics)--Complications | Labor Fetal AnoxiaUnited States
-
Raydiant Oximetry, Inc.TerminatedFetal Hypoxia | Fetal Distress | Fetal Acidemia | Fetal or Neonatal Effect of Complication of LaborUnited States
-
Alzahraa Ismail Ragheb GodaUnknownDelivery ,Complications,Maternal | Delivery,Complication,FetalEgypt
-
University of LisbonUnknownFetal Monitoring | Labor Fetal Anoxia
-
Montefiore Medical CenterTerminatedFetal Death | Intrauterine Fetal DemiseUnited States
-
Shaare Zedek Medical CenterUnknownPremature Rupture of Fetal Membranes
-
Medstar Health Research InstituteSequenom LaboratoriesCompletedMiscarriage | Intrauterine Fetal Demise | Circulating Cell Free Fetal DNAUnited States
-
Hillel Yaffe Medical CenterUnknownPremature Rupture of Fetal MembranesIsrael
-
Monash UniversityNational Health and Medical Research Council, Australia; Cerebral Palsy Alliance and other collaboratorsRecruitingFetal Growth Retardation | Pregnancy Preterm | Stillbirth and Fetal DeathAustralia, New Zealand
Clinical Trials on Doppler flow indices assessment
-
Montreal Heart InstituteCompletedSurgery--Complications | Anesthesia | Congestive Heart Failure | Right Heart Failure | Venous CongestionCanada
-
Cairo UniversityUnknownFetal MalnutritionEgypt
-
RenJi HospitalNot yet recruitingRecurrent MiscarriageChina
-
Samuel Lunenfeld Research Institute, Mount Sinai...Completed
-
Institute of Mother and Child, Warsaw, PolandBielanski HospitalRecruitingFetal Growth RestrictionPoland
-
Ain Shams UniversityCompletedRespiratory Distress Syndrome, NewbornEgypt
-
Yasser S Mostafa, MDFayoum University HospitalRecruiting
-
Gaziler Physical Medicine and Rehabilitation Education...Completed
-
Kudret Atakan TekinRecruitingArteriovenous FistulaTurkey
-
Ann Marie ChikowskiMain Line HealthCompletedDilated Cardiomyopathy | Congestive Heart Failure | Ischemic Congestive CardiomyopathyUnited States